0001493152-19-017472.txt : 20191114
0001493152-19-017472.hdr.sgml : 20191114
20191114161534
ACCESSION NUMBER: 0001493152-19-017472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190603
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lisi Steven A.
CENTRAL INDEX KEY: 0001702628
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 191220376
MAIL ADDRESS:
STREET 1: 2 ILAN RAMON, SCIENCE PARK
CITY: NESS ZIONA
STATE: L3
ZIP: 7403635
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4
1
ownership.xml
X0306
4
2019-06-03
0
0001641631
Beyond Air, Inc.
XAIR
0001702628
Lisi Steven A.
C/O BEYOND AIR, INC.
825 EAST GATE BOULEVARD, SUITE 320
GARDEN CITY,
NY
11530
1
1
0
0
CEO, Chairman
Common Stock
2019-06-03
4
P
0
58253
5.15
A
581318
D
Common Stock
2019-11-11
4
P
0
10000
4.19
A
591318
D
Common Stock
2019-11-12
4
P
0
8000
4.07
A
599318
D
Common Stock
2019-11-13
4
P
0
12000
4.09
A
611318
D
Closing price of common stock on May 31, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.10 to $4.3452, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.051 to $4.14, inclusive.
/s/ Steven A. Lisi
2019-11-14